Cas:2870-04-4 m-Xylene, 2-ethyl- manufacturer & supplier

We serve Chemical Name:m-Xylene, 2-ethyl- CAS:2870-04-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

m-Xylene, 2-ethyl-

Chemical Name:m-Xylene, 2-ethyl-
CAS.NO:2870-04-4
Synonyms:2-ethyl-m-xylene;BENZENE,2-ETHYL-1,3-DIMETHY;benzene,1-ethyl-2,6-dimethyl;1,3-dimethyl-2-ethylbenzene;Benzene, 2-ethyl-1,3-dimethyl-;2-ethyl-1,3-dimethyl-benzen;2-Aethyl-1,3-dimethyl-benzol;m-Xylene, 2-ethyl-;Ethyl-2,6-dimethylbenzene;m-Xylene,2-ethyl;2-Ethyl-1,3-dimethylbenzene;1-ethyl-2,6-dimethylbenzene;1,3-dimethyl-3-ethylbenzene;2-ethyl-3-methyltoluene
Molecular Formula:C10H14
Molecular Weight:134.218
HS Code:2902909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:190.2±20.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.499
PSA:
Exact Mass:134.109543
LogP:4.13

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-ethyl-m-xylene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-ethyl-3-methyltoluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Aethyl-1,3-dimethyl-benzol Use and application,m-Xylene,2-ethyl technical grade,usp/ep/jp grade.


Related News: ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� m-Xylene, 2-ethyl- manufacturer ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� m-Xylene, 2-ethyl- supplier In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better. m-Xylene, 2-ethyl- vendor ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� m-Xylene, 2-ethyl- factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.